17β-Hydroxysteroid dehydrogenase III deficiency: Difference between revisions
CSV import |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = 17β-Hydroxysteroid dehydrogenase III deficiency | |||
| image = [[File:Androstediona3D.png|Androstedione 3D]] | |||
| caption = Biosynthesis pathway involving 17β-Hydroxysteroid dehydrogenase III | |||
| synonyms = 17β-HSD3 deficiency, 17-ketosteroid reductase deficiency | |||
| field = [[Endocrinology]] | |||
| symptoms = [[Ambiguous genitalia]], [[undescended testes]], [[infertility]] | |||
| complications = [[Gender dysphoria]], [[osteoporosis]] | |||
| onset = [[Prenatal]] | |||
| duration = Lifelong | |||
| causes = Mutations in the [[HSD17B3]] gene | |||
| risks = Genetic inheritance (autosomal recessive) | |||
| diagnosis = [[Genetic testing]], [[hormone levels]] | |||
| differential = [[Androgen insensitivity syndrome]], [[5α-reductase deficiency]] | |||
| prevention = Genetic counseling | |||
| treatment = [[Hormone replacement therapy]], [[surgical intervention]] | |||
| medication = [[Testosterone]] | |||
| prognosis = Variable, depending on treatment | |||
| frequency = Rare | |||
}} | |||
[[File:Test_biosynth_17BHSD3.jpg|500px|left]] | |||
'''17β-Hydroxysteroid dehydrogenase III deficiency''' ('''17β-HSD3 deficiency''') is a rare [[endocrine disorder]] affecting the [[biosynthesis]] of [[testosterone]], an important [[hormone]] in the development of male [[sexual characteristics]]. This condition is part of a group of disorders known as [[intersex]] conditions, which involve discrepancies between the external [[genitals]] and the [[genetic sex]]. | '''17β-Hydroxysteroid dehydrogenase III deficiency''' ('''17β-HSD3 deficiency''') is a rare [[endocrine disorder]] affecting the [[biosynthesis]] of [[testosterone]], an important [[hormone]] in the development of male [[sexual characteristics]]. This condition is part of a group of disorders known as [[intersex]] conditions, which involve discrepancies between the external [[genitals]] and the [[genetic sex]]. | ||
| Line 25: | Line 46: | ||
[[Category:Genetic diseases and disorders]] | [[Category:Genetic diseases and disorders]] | ||
{{rarediseases}} | {{rarediseases}} | ||
Latest revision as of 02:58, 25 March 2025
| 17β-Hydroxysteroid dehydrogenase III deficiency | |
|---|---|
| |
| Synonyms | 17β-HSD3 deficiency, 17-ketosteroid reductase deficiency |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Ambiguous genitalia, undescended testes, infertility |
| Complications | Gender dysphoria, osteoporosis |
| Onset | Prenatal |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the HSD17B3 gene |
| Risks | Genetic inheritance (autosomal recessive) |
| Diagnosis | Genetic testing, hormone levels |
| Differential diagnosis | Androgen insensitivity syndrome, 5α-reductase deficiency |
| Prevention | Genetic counseling |
| Treatment | Hormone replacement therapy, surgical intervention |
| Medication | Testosterone |
| Prognosis | Variable, depending on treatment |
| Frequency | Rare |
| Deaths | N/A |
17β-Hydroxysteroid dehydrogenase III deficiency (17β-HSD3 deficiency) is a rare endocrine disorder affecting the biosynthesis of testosterone, an important hormone in the development of male sexual characteristics. This condition is part of a group of disorders known as intersex conditions, which involve discrepancies between the external genitals and the genetic sex.
Overview[edit]
17β-HSD3 deficiency is caused by mutations in the HSD17B3 gene, which encodes the 17β-hydroxysteroid dehydrogenase type 3 enzyme. This enzyme plays a crucial role in the steroidogenesis pathway, converting androstenedione (an androgen precursor) into testosterone. When the activity of this enzyme is impaired due to genetic mutations, the production of testosterone is significantly reduced, leading to the development of female external genitalia in genetically male individuals (46,XY karyotype).
Symptoms and Diagnosis[edit]
Individuals with 17β-HSD3 deficiency are typically assigned female at birth due to the presence of female-like external genitalia. However, at puberty, virilization may occur, including the development of male secondary sexual characteristics such as increased muscle mass, deepening of the voice, and growth of facial hair. Some individuals may also experience cryptorchidism (undescended testes) or have a small phallus.
Diagnosis is usually made through a combination of clinical examination, hormone assays (showing elevated levels of androstenedione and low levels of testosterone), and genetic testing for mutations in the HSD17B3 gene.
Treatment[edit]
Treatment for 17β-HSD3 deficiency is tailored to the individual's needs and may include hormone replacement therapy (HRT) to address hormone imbalances and surgical interventions to modify the appearance of the genitalia if desired by the individual. Psychological support is also an important aspect of treatment, given the complex issues related to gender identity and psychosocial well-being.
Epidemiology[edit]
17β-HSD3 deficiency is a very rare condition, with a higher prevalence reported in certain populations due to the founder effect, such as in the Gaza Strip. The exact incidence worldwide is unknown.
See Also[edit]
NIH genetic and rare disease info[edit]
17β-Hydroxysteroid dehydrogenase III deficiency is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - 17β-Hydroxysteroid dehydrogenase III deficiency
|
